Rosmarinic Acid


Rosmarinus officinalis, Perilla frutescens, Prunella vulgaris, Melissa officinalis, Salvia, Borago officinalis, Lithosperma, Lycopus virginicus, Thymus vulgaris, Mentha piperita.


Autoimmune disease, inflammation, and allergies (e.g., food and respiratory, including asthma).

Mechanism of Action

Rosmarinic acid has many complex actions on inflammatory cascades including inhibition of cytokine release from activated T cells and prevention of T-cell activation in the first place. Rosmarinic acid’s mechanisms of action are becoming increasingly intricate, technical, and complex as the field of immunology and research techniques advance. Without detailing all of the molecular actions, rosmarinic acid limits the production of proinflammatory mediators1,2,3,4 while promoting anti-inflammatory mediators5; protecting the lungs,6,7 vasculature,8 and skin9; reducing mortality in animal models of sepsis10,11; reducing pain through antinociceptive effects12; and displaying anticancer and chemopreventative effects.13 In short, T cells are up-regulated or down-regulated in response to various chemical, infectious, oxidative, toxic, and other influences, and rosmarinic acid may both improve immune responses in cases of cancer or infection and decrease immune hyper-reactivity in allergic and autoimmune situations.14

In general, in allergic situations such as asthma, dermatitis, and chemical reactivity involve activation of T cells and mast cells and their release of proinflammatory interferon and interleukins. Nuclear factor-κB (NF-κB) and tumor necrosis factor (TNF)-α are several agents at the top of the inflammatory cascade that activate T cells, including CD4 and CD8 cells, and rosmarinic acid inhibits their expression.15,16 Rosmarinic acid’s inhibition of TNF-α and NF-κB activation may protect the kidneys from nephrotoxins,16 the liver from fibrosis,17,18 and tissues from ischemic cytotoxicity.19

T-Cell Activation: Nuclear DNA possesses a multitude of binding sites, and one in particular, the Src Homology 2 (SH2) domain, directs T-cell activities in the body and thus plays role in cancer, autoimmune diseases, and inflammatory diseases. Rosmarinic acid has been shown to act as an agonist to the SH2 domain and reduce T-cell activation via several common T-cell antigens and inflammatory mediators. Furthermore, rosmarinic acid has been shown to reduce the ability of activated T cells to promote interleukin production and release.20

Protein Kinase Signal Transduction: Another mechanism of T-cell inhibition may involve protein kinase enzymes. There are numerous protein kinases that play important roles in translating signals from cellular receptors and the outside of cells to the interior and ultimately act on the cellular DNA to direct the activity of that cell. This process is called signal transduction, and protein kinases are one type of enzymes on the interior of the cell membrane that are involved with signal transduction.

One group of protein kinases are a family of tyrosine-based kinases, and one in particular, named Lck, is specific to T-cell signal transduction. Rosmarinic acid has been shown to inhibit activity between these tyrosine kinase enzymes and downstream peptides, thereby reducing signal transduction in T cells.21 Researchers report that T-cell apoptosis is promoted when Lck pathways are interfered with and that the apoptosis is restricted to actively proliferating cell and does not affect cells at rest.22 This is extremely significant as it suggests that rosmarinic acid may reduce hyperactive immune response and yet not impair healthy T cells or appropriate lymphocyte functioning, as do the immunosuppressive drugs.

T-Cell Receptors: T-cell antigen receptors are located on the T-lymphocyte cell surface, enabling the cell to recognize and respond to outside influences, microbes, and a wide a variety of antigens. Binding of an antigen or other activator to these receptors promotes several reactive processes inside the cell. The molecules involved with transducing the signal to the nuclear DNA are called transcription factors, and one such molecule is the nuclear factor of activated T cells. Another is simply called activating protein. A domino effect of molecular activation can ultimately lead to T-cell activation, the release of interleukins from T cells, and the promotion of inflammatory and immune responses. Rosmarinic acid has been found to inhibit nuclear factor of activated T cells, but not activating protein.23 Because the nuclear factor of activated T cells is mediated by calcium ions and the activating protein is not, researchers feel that rosmarinic acid may inhibit pathways involving calcium signaling. Rosmarinic acid also has direct effect on antigen receptors on T cells by blocking signal transduction at the membrane including blockade of nuclear factors and kinase enzymes and tyrosine phosphorylation.23

Autoimmune Disease: One group of researchers showed that rosmarinic acid was able to induce apoptosis of T cells taken from rheumatoid arthritis patients.24 The mechanism seems to be that rosmarinic acid induces the release of cytochrome c from mitochondria that, in turn, plays a role in inducing apoptosis of the aberrant T cells.22

An animal model of collagen-induced arthritis has shown rosmarinic acid to reduce inflammation by several mechanisms. Animals treated with rosmarinic acid displayed “remarkably reduced” synovial inflammatory markers, such as cyclooxygenase according to researchers, compared with the control animals.25

Rosmarinic acid is also being explored as a medicine to reduce transplant rejection. Animal research revealed that rosmarinic acid may reduce antibodies from attacking the transplanted tissue. One group of researchers investigated the ability of rosmarinic acid alone and in combination with the immunosuppressive drugs cyclosporine, prednisone, or rapamycin to inhibit proliferation of splenic
T cells in animals having undergone skin graft procedures as a model of graft versus host disease. The study showed that rosmarinic acid worked synergistically with immunosuppressive drugs and increased their ability to reduce transplant rejection.26 This might mean that a lower dose of the harsh immunosuppressant would be required if used in tandem with rosmarinic acid.

Antivenom, Collagen, and Tissue-Protecting Effects: Rosmarinic acid inhibits the classical complement pathway that may be induced my venom, bacterial infection, and other toxins and prevents sepsis, hemolysis, and tissue destruction,27 in part by preventing connective tissue destruction and supporting cell survival. Rosmarinic acid exerts antiaging effects on the skin, protecting against tyrosinase-, hyaluronidase-, elastase-, and collagenase-induced breakdown of the connective tissue support tissue.28

Rosmarinic acid shows potential as an antidote to toxic snake bites by neutralizing venom-induced hemorrhage and breakdown of collagen.29,30,31 Rosmarinic acid prevents the venom’s hemorrhagic effects by inhibiting the breakdown in fibrinogen and collagen.29 Phospholipases A₂ are the most abundant muscle-damaging components of snake venom, and rosmarinic acid drastically reduces both the muscle damage and the neuromuscular blockade exerted by phospholipase activation.32

Although not all clinicians will have the need for snake bite remedies, the ability of rosmarinic acid to protect against connective tissue destruction may also offer protection in collagen vascular and autoimmune conditions. For example, rosmarinic acid exerts a hepatoprotective effect17; supports periodontal gingival tissue15; and inhibits the migration, adhesion, and invasion of tumor cells33 via stabilizing effects on T cells and limiting cytokines-driven breakdown of connective tissues.34

Rosmarinic acid may protect glomerular function in diabetes by reducing activation of fibronectin, collagen, and fibrin that contributes to expansion and fibrosis of the glomerular matrix,35,36 protect against the proliferation of mesangial cells in animal models of glomerulonephritis,36 and protect against cisplatin-induced nephrotoxicity.16 Connective tissue growth factor plays a pathogenic role in diabetic nephropathy, and rosmarinic acid inhibits connective tissue growth factor stimulated by hyperglycemia, helping protect proximal tubular epithelial cells of the kidneys in animal models of nephropathy.37,38

Transplanting functional pancreatic islets is being explored as a therapeutic option in type I diabetes, but the transplants are often rejected because of the background inflammatory state of the pancreas. Pharmaceutical immunosuppressants have debilitating side effects, and rosmarinic acid is suggested to be an effective adjuvant to monoclonal antibodies, reducing cytokine expression and T-cell infiltration and preventing apoptosis in transplanted cells.39

Evidence-Based Research

Rosmarinic acid’s effects on T cells and the release of inflammatory cytokines are shown to benefit chronic inflammatory disease, acute and chronic allergic phenomena, and autoimmune diseases. Rosmarinic acid has antimicrobial,40 antioxidant,41 and anti-inflammatory activity11,42,43,44,45 that contributes to its effects in medical conditions as varied as hayfever4 to organ rejection in transplant patients39,46,47 to acute snake bite30,31 because of its significant ability to limit inflammatory and toxic processes. Rosmarinic acid attenuates inflammation as a result of chemical irritants48 and allergic disorders4,6; protects neurons in situations of oxidative and ischemic stress19; slows the development of Alzheimer’s disease18,49,50; protects dopaminergic cells in animal models of Parkinson’s disease51; and may reduce inflammation in rheumatoid arthritis, allergic airway disease, atopic conditions, and chronic inflammation, such as diabetes.

Rosmarinic acid reduces oxidative stress and the resultant release of inflammatory compounds,52 limits the activation of complement pathways,53 reduces allergic immunoglobulin and cytokine responses, and attenuates the release of proinflammatory cytokines from activated T cells. T cells are among the most prominent lymphocytes involved in both allergic and autoimmune diseases. Rosmarinic acid may offer a safer alternative to inhibiting T cells than immunosuppressive drugs for allergy and autoimmune disease patients and help control pathologic progression in chronic inflammatory diseases such glomerulonephritis. Autoimmune diseases involve aberrant T-cell activity. For example, T cells play a large role in initiating and perpetuating rheumatoid arthritis54 commonly managed with immunosuppressive drugs as a means of controlling pain, symptoms, and skin, tissue, and joint destruction. Research is emerging showing that rosmarinic acid can induce T-cell apoptosis24 and reduce autoinflammatory activity in a similar manner, but without the risks and long-term side effects of the immunosuppressive drugs.

Allergic Airway Diseases: Airborne pollutants, such as diesel exhaust particles, are believed to contribute to the increasing rates of allergies, asthma, and lung diseases in the general public.55 Animal models of lung disease have shown intratracheal instillation of diesel exhaust particles to generate reactive oxygen species. One study showed rosmarinic acid to prevent lung inflammation when animals were supplemented orally with rosmarinic acid and then exposed to diesel exhaust.6 The increases in interleukins and several inflammatory proteins normally elevated by diesel particle inhalation were all inhibited by rosmarinic acid, as was the infiltration of neutrophils in the lung tissue and local interstitial edema.

One mouse model of allergic asthma sensitized tracheal tissue with dust mite exposure, inducing eosinophilic inflammation, and then measured interleukins and eotaxin. Eotaxin is a cytokine that activates eosinophils, the type of white blood cell most commonly elevated in allergic conditions. Pretreatment with a high rosmarinic acid Perilla showed that it was able to prevent the eosinophilic inflammatory response.3 The researchers also reported that interleukins and eotaxin elevations were inhibited by rosmarinic acid. Similar effects are seen in animal models of atopic dermatitis.14

Human Clinical Trials on Asthma: One human trial on allergic rhinoconjunctivitis investigated the effects of rosmarinic acid-enriched Perilla extract. The 21-day study administered either the Perilla–rosmarinic acid combo at a dose of 200 mg in 10 subjects and 50 mg in nine additional subjects or a placebo and evaluated logs of patient's symptoms as well as evaluated nasal lavage samples for inflammatory cells. At the end of the 3 weeks, the group receiving the rosmarinic acid reported fewer symptoms (including itchy nose, itchy eyes, and watery eyes) compared with the group receiving the placebo. Furthermore, the nasal lavage contained significantly fewer neutrophils and eosinophils.56

Another nearly identical study by the same researchers administered rosmarinic acid to seasonal allergic rhinitis sufferers and examined nasal lavage–obtained cells and cytokine concentration in dosed patients compared with placebo-treated controls. Rosmarinic acid supplementation was shown to decrease the numbers of neutrophils and eosinophils in nasal lavage fluid.57

The results of these animal and human investigations suggest that rosmarinic acid ameliorates increases in cytokines, chemokines, and allergen-specific antibodies in allergic airway diseases.3

Safety in Pregnancy and Breastfeeding

There have been no investigations on the use rosmarinic acid in pregnancy and lactation to date. Animal investigations in milk goats have found rosemary consumption to have no deleterious effects on milk quantity or quantity.58 Because of the historical use of rosemary and related herbs that contain rosmarinic acid as culinary spices, it is generally assumed that moderate consumption of rosemary and Perilla is safe during pregnancy and lactation, but less can be assumed for isolated and concentrated rosmarinic acid.

General Safety

Rosmarinic acid is considered safe and well tolerated. One clinical study that investigated rosmarinic acid in allergic rhinitis patients reported no adverse events, and no significant abnormalities were detected in routine blood tests.56


Animal studies have dosed 1–5 mg/kg.59

Rosmarinic acid is generally considered safe; typical formulas use 12–100 mg per capsule.

Traditional Uses

Rosmarinic acid is a caffeic acid derivative that occurs in occurs in several plants in addition to rosemary (Rosmarinus), including Perilla, Prunella, Melissa, Salvia, Borago, and Lithosperma. Many of these plants have been used traditionally for upper respiratory symptoms and occasionally allergic phenomena. Rosmarinic acid may now be produced in plant cell cultures. Rosmarinic acid is one of the most abundant caffeic esters occurring in plants. It seems to be most active in humans when it becomes auto-oxidized.60

Rosmarinic acid is reportedly fairly well absorbed from the gastrointestinal tract and may have some capacity for dermal absorption as well. It seems to be readily assimilated by all of the major organs, with the highest concentrations seen in the lungs. This may explain why plants high in rosmarinic acid are traditionally used to treat asthma and respiratory allergies.

Studies on each of these individual herbs noted to be high in rosmarinic acid include numerous reports of antiinflammatory actions. Rosmarinus,61 Salvia,62,63 and Perilla64 have powerful antioxidant actions, much of which is now being credited to immune-modulating effects or rosmarinic acid. Perilla frutescens is a popular culinary garnish and part of the Asian herbal medicine tradition used for allergies41,65 and as an antidote for allergic reactivity to fish and crab ingestion, and for bronchial asthma.



J Agric Food Chem. 2009;57(22):10579–89. Rosmarinic acid in Prunella vulgaris ethanol extract inhibits lipopolysaccharide-induced prostaglandin E2 and nitric oxide in RAW 264.7 mouse macrophages. Huang N, Hauck C, Yum MY, Rizshsky L, Widrlechner MP, McCoy JA, Murphy PA, Dixon PM, Nikolau BJ, Birt DF.

2 Planta Med. 2013;79(17):1605–14. Systemic administration of Rosmarinus officinalis attenuates the inflammatory response induced by carrageenan in the mouse model of pleurisy. da Rosa JS, Facchin BM, Bastos J, Siqueira MA, Micke GA, Dalmarco EM, Pizzolatti MG, Fröde TS.

3 Clin Exp Allergy. 2004;34(6):971–7. Rosmarinic acid in perilla extract inhibits allergic inflammation induced by mite allergen, in a mouse model. Sanbongi C, Takano H, Osakabe N, Sasa N, Natsume M, Yanagisawa R, Inoue KI, Sadakane K, Ichinose T, Yoshikawa T.

4 Exp Biol Med (Maywood). 2011;236(1):99–106. Effect of Perilla frutescens var. acuta Kudo and rosmarinic acid on allergic inflammatory reactions. Oh HA, Park CS, Ahn HJ, Park YS, Kim HM.

5 Food Funct. 2015;6(3):927–31. Effects of rosmarinic acid on liver and kidney antioxidant enzymes, lipid peroxidation and tissue ultrastructure in aging mice. Zhang Y, Chen X, Yang L, Zu Y, Lu Q.

6 Free Radic Biol Med. 2003;34(8):1060–9. Rosmarinic acid inhibits lung injury induced by diesel exhaust particles. Sanbongi C, Takano H, Osakabe N, Sasa N, Natsume M, Yanagisawa R, Inoue K, Kato Y, Osawa T, Yoshikawa T.

7 Int J Mol Med. 2005;16(2):315–9. Effects of volatile constituents of a rosemary extract on allergic airway inflammation related to house dust mite allergen in mice. Inoue K, Takano H, Shiga A, Fujita Y, Makino H, Yanagisawa R, Ichinose T, Kato Y, Yamada T, Yoshikawa T.

8 Food Chem Toxicol. 2013;59:311–5. Rosmarinic acid down-regulates endothelial protein C receptor shedding in vitro and in vivo. Ku SK, Yang EJ, Song KS, Bae JS.

9 Arch Dermatol Res. 2010;302(3):171–81. Prunella vulgaris extract and rosmarinic acid prevent UVB-induced DNA damage and oxidative stress in HaCaT keratinocytes. Vostálová J, Zdarilová A, Svobodová A.

10 Br J Pharmacol. 1985;84(2):317–27. Modification of endotoxin-induced haemodynamic and haematological changes in the rabbit by methylprednisolone, F(ab’)2 fragments and rosmarinic acid. Bult H, Herman AG, Rampart M.

11 Shock. 2009;32(6):608–13. Rosmarinic acid protects against experimental sepsis by inhibiting proinflammatory factor release and ameliorating hemodynamics. Jiang WL, Chen XG, Qu GW, Yue XD, Zhu HB, Tian JW, Fu FH.

12 Pharmacol Biochem Behav. 2014;124:67–73. Antinociceptive and anti-inflammatory effects of rosmarinic acid isolated from Thunbergia laurifolia Lindl. Boonyarikpunchai W, Sukrong S, Towiwat P.

13 Mol Nutr Food Res. 2012;56(5):775–83. Dietary intake of rosmarinic acid by Apc(Min) mice, a model of colorectal carcinogenesis: levels of parent agent in the target tissue and effect on adenoma development. Karmokar A, Marczylo TH, Cai H, Steward WP, Gescher AJ, Brown K.

14 Int Immunopharmacol. 2011;11(9):1271–7. Rosmarinic acid attenuates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice. Jang AH, Kim TH, Kim GD, Kim JE, Kim HJ, Kim SS, Jin YH, Park YS, Park CS.

15 Toxicol In Vitro. 2009;23(3):386–92. Prunella vulgaris extract and rosmarinic acid suppress lipopolysaccharide-induced alteration in human gingival fibroblasts. Zdarilová A, Svobodová A, Simánek V, Ulrichová J.

16 Food Chem Toxicol. 2014;66:321–8. Nephroprotective activities of rosmarinic acid against cisplatin-induced kidney injury in mice. Domitrović R, Potočnjak I, Crnčević-Orlić Z, Škoda M.

17 Basic Clin Pharmacol Toxicol. 2015;116(5):398–413. Anti-inflammatory effect of rosmarinic acid and an extract of Rosmarinus officinalis in rat models of local and systemic inflammation. Rocha J, Eduardo-Figueira M, Barateiro A, Fernandes A, Brites D, Bronze R, Duarte CM, Serra AT, Pinto R, Freitas M, Fernandes E, Silva-Lima B, Mota-Filipe H, Sepodes B.

18 Crit Rev Biotechnol. 2012;32(3):203–17. Rosmarinic acid and its derivatives: biotechnology and applications. Bulgakov VP, Inyushkina YV, Fedoreyev SA.

19 J Neuroinflammation. 2013;10:28. Rosmarinic acid protects against experimental diabetes with cerebral ischemia: relation to inflammation response. Luan H, Kan Z, Xu Y, Lv C, Jiang W.

20 Bioorg Med Chem. 2007;15(11):3938–50. The structure-activity relationship of the series of non-peptide small antagonists for p56lck SH2 domain. Park SH, Oh HS, Kang MA, Cho H, Prasad JB, Won J, Lee KH.

21 Eur J Immunol. 33(4):870–9. Rosmarinic acid inhibits TCR-induced T cell activation and proliferation in an
Lck-dependent manner.
Won J, Hur Y-G, Hur EM, Park S-H, Kang M-A, Choi Y, Park C, Lee K-H, Yun Y.

22 J Immunol. 2004;172(1):79–87. Rosmarinic acid induces p56lck-dependent apoptosis in Jurkat and peripheral
T cells via mitochondrial pathway independent from Fas/Fas ligand interaction.
Hur Y-G, Yun Y, Won J.

23 Blood. 2003;101(9):3534–42. Rosmarinic acid inhibits Ca2+-dependent pathways of T-cell antigen receptor-mediated signaling by inhibiting the PLC-1 and Itk activity. Kang M-A, Yun S-Y, Won J.

24 J Clin Immunol. 2007;27(1):36–45. Rosmarinic acid induces apoptosis of activated T cells from rheumatoid arthritis patients via mitochondrial pathway. Hur YG, Suh CH, Kim S, Won J.

25 J Rheumatol. 2003;30(6):1203–7. Beneficial effects of rosmarinic acid on suppression of collagen induced arthritis. Youn J, Lee K-H, Won J, Huh S-J, Yun H-S, Cho W-G, Paik D-J.

26 Transplantation. 2003;75(10):1758–60. Synergistic immunosuppressive effects of rosmarinic acid and rapamycin in vitro and in vivo1. Yun S-Y, Hur Y-G, Kang M-A, Lee J, Ahn C, Won J.

27 Int J Immunopharmacol. 1988;10(6):729–37. Rosmarinic acid: a new inhibitor of complement C3-convertase with anti-inflammatory activity. Englberger W, Hadding U, Etschenberg E, Graf E, Leyck S, Winkelmann J, Parnham MJ.

28 Curr Med Chem. 2015;22(12):1515–38. Potential role of natural compounds against skin aging. Tundis R, Loizzo MR, Bonesi M, Menichini F.

29 Toxins (Basel). 2010;2(10):2478–89. Biological and pathological studies of rosmarinic acid as an inhibitor of hemorrhagic Trimeresurus flavoviridis (habu) venom. Aung HT, Nikai T, Komori Y, Nonogaki T, Niwa M, Takaya Y.

30 Clin Toxicol (Phila.). 2014;52(2):118–20. Trypsin and rosmarinic acid reduce the toxicity of Micrurus fulvius venom in mice. Parker-Cote JL, O’Rourke DP, Miller SN, Brewer KL, Rosenbaum MD, Meggs WJ.

31 J Nat Med. 2010;64(4):482–6. Rosmarinic acid in Argusia argentea inhibits snake venom-induced hemorrhage. Aung HT, Nikai T, Niwa M, Takaya Y.

32 PLoS One. 2011;6(12):e28521. Structural and functional studies of a bothropic myotoxin complexed to rosmarinic acid: new insights into Lys49-PLA₂ inhibition. Dos Santos JI, Cardoso FF, Soares AM, Dal Pai Silva M, Gallacci M, Fontes MR.

33 J Cell Biochem. 2010;111(2):370–9. Anti-invasion effect of rosmarinic acid via the extracellular signal-regulated kinase and oxidation-reduction pathway in Ls174-T cells. Xu Y, Xu G, Liu L, Xu D, Liu J.

34 J Cell Physiol. 2013;228(5):975–82. Barrier protective effects of rosmarinic acid on HMGB1-induced inflammatory responses in vitro and in vivo. Yang EJ, Ku SK, Lee W, Lee S, Lee T, Song KS, Bae JS.

35 J Pharm Pharmacol. 2013;65(5):713–23. Rosmarinic acid administration attenuates diabetes-induced vascular dysfunction of the rat aorta. Sotnikova R, Okruhlicova L, Vlkovicova J, Navarova J, Gajdacova B, Pivackova L, Fialova S, Krenek P.

36 Nephron. 2002;92(4):898–904. Suppressive effects of rosmarinic acid on mesangioproliferative glomerulonephritis in rats. Makino T, Ono T, Liu N, Nakamura T, Muso E, Honda G.

37 Basic Clin Pharmacol Toxicol. 2012;110(4):390–5. Effect of rosmarinic acid on experimental diabetic nephropathy. Jiang WL, Xu Y, Zhang SP, Hou J, Zhu HB.

38 Phytomedicine. 2010;17(3–4):282–8. In vitro and in vivo antifibrotic effects of rosmarinic acid on experimental liver fibrosis. Li GS, Jiang WL, Tian JW, Qu GW, Zhu HB, Fu FH.

39 Exp Mol Med. 2008;40(1):1–10. Prolonged survival of islet allografts in mice treated with rosmarinic acid and anti-CD154 antibody. Jung da Y, Kim EY, Joo SY, Park JB, Moon C, Kim SH, Sim EY, Joh JW, Kwon CH, Kwon GY,
Kim SJ.

40 Antimicrob Agents Chemother. 2007;51(9):3367–70. Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis. Swarup V, Ghosh J, Ghosh S, Saxena A, Basu A.

41 Bioorg Med Chem. 1998;6(7):1051–6. Antiallergic activities of rabdosiin and its related compounds: chemical and biochemical evaluations. Itoa H, Miyazakia T, Onoa M, Sakuraib H.

42 J Am Oil Chem Soc. 1996;73(5):645. Antioxidative activity and phenolic composition of pilot-plant and commercial extracts of sage and rosemary. Cuvelier M-E, Richard H, Berset C.

43 Biochem Pharmacol. 1983;32(22):325–33. RHC 3288 [1-methyl-2(1,3,4-oxadiazol-2(3H)-one-5-yl) benzimidazole] and related compounds: Novel inhibitors of histamine release from rat mast cells and human basophils. Khandwala A, Coutts S, Dally-Meade V, Jariwala N, Musser J, Brown R, Jones H, love B, Weinryb I.

44 Int J Immunopharmacol. 1983;5(6):491–502. Antiallergic activity profile in vitro of RHC 2963 and related compounds. Khandwala A, Van Inwegen R, Coutts S, Dally-Meade V, Youssefyeh RD.

45 Pharm Acta Helv. 1991;66(7):185–8. Medicinal Lamiaceae with antioxidant properties, a potential source of rosmarinic acid. Lamaison JL, Petitjean-Freytet C, Carnat A.

46 Curr Opin Hematol. 2010;17(6):493–9. High-dose cyclophosphamide for graft-versus-host disease prevention. Luznik L, Jones RJ, Fuchs EJ.

47 Expert Opin Ther Pat. 2010;20(11):1573–93. Update on lymphocyte specific kinase inhibitors: a patent survey. Martin MW, Machacek MR.

48 Pharm Biol. 2013;51(9):1087–90. In vivo analgesic and anti-inflammatory activities of Rosmarinus officinalis aqueous extracts, rosmarinic acid and its acetyl ester derivative. Lucarini R, Bernardes WA, Ferreira DS, Tozatti MG, Furtado R, Bastos JK, Pauletti PM, Januário AH, Silva ML, Cunha WR.

49 Appl Microbiol Biotechnol. 2015;99(5):2083–92. Production and applications of rosmarinic acid and structurally related compounds. Kim GD, Park YS, Jin YH, Park CS.

50 Chem Asian J. 2013;8(3):596–602. Natural compounds against Alzheimer’s disease: molecular recognition of Aβ1-42 peptide by Salvia sclareoides extract and its major component, rosmarinic acid, as investigated by NMR. Airoldi C, Sironi E, Dias C, Marcelo F, Martins A, Rauter AP, Nicotra F, Jimenez-Barbero J.

51 J Mol Neurosci. 2012;47(1):113–9. Neurorescue effect of rosmarinic acid on 6-hydroxydopamine-lesioned nigral dopamine neurons in rat model of Parkinson’s disease. Wang J, Xu H, Jiang H, Du X, Sun P, Xie J.

52 J Proteome Res. 2011;10(2):837–44. Metabolomic approach with LC-QTOF to study the effect of a nutraceutical treatment on urine of diabetic rats. Godzien J, Ciborowski M, Angulo S, et al.

53 Fresenius J Anal Chem. 1995;351(2–3):311–4. Spectrophotometric determination of rosmarinic acid in plant cell cultures by complexation with Fe2+ ions. López-Arnaldos T, López-Serrano M, Barceló AR, Calderón AA, Zapata JM.

54 Clin Immunol. 2009;132(3):295–304. Breaking old paradigms: Th17 cells in autoimmune arthritis. Peck A,
Mellins ED.

55 Toxicol Appl Pharmacol. 2000;168(2):140–8. Effect of ozone on diesel exhaust particle toxicity in rat lung. Madden MC, Richards JH, Dailey LA, Hatch GE, Ghio AJ.

56 Exp Biol Med (Maywood). 2004;229(3):247–54. Extract of Perilla frutescens enriched for rosmarinic acid, a polyphenolic phytochemical, inhibits seasonal allergic rhinoconjunctivitis in humans. Takano H, Osakabe N, Sanbongi C, Yanagisawa R, Inoue K-I, Yasuda A, Natsume M, Baba S, Ichiishi E-I, Yoshikawa T.

57 Biofactors. 2004;21(1–4):127–31. Anti-inflammatory and anti-allergic effect of rosmarinic acid (RA); inhibition of seasonal allergic rhinoconjunctivitis (SAR) and its mechanism. Osakabe N, Takano H, Sanbongi C, Yasuda A, Yanagisawa R, Inoue K-I, Yoshikawa T.

58 J Agric Food Chem. 2010;58(14):8265–70. Introduction of distillate rosemary leaves into the diet of the Murciano-Granadina goat: transfer of polyphenolic compounds to goats’ milk and the plasma of suckling goat kids. Jordán MJ, Moñino MI, Martínez C, Lafuente A, Sotomayor JA.

59 Life Sci. 2015;122:65–71. Antiepileptogenic, antioxidant and genotoxic evaluation of rosmarinic acid and its metabolite caffeic acid in mice. Coelho VR, Vieira CG, de Souza LP, Moysés F, Basso C, Papke DK, Pires TR, Siqueira IR, Picada JN, Pereira P.

60 Endocrinology. 1985;116(5):1677–86. The active principles of plant extracts with antithyrotropic activity: oxidation products of derivatives of 3,4-dihydroxycinnamic acid. Auf’mkolk M, Amir SM, Kubota K, Ingbar SH.

61 Food Chem. 2008;110(1):76–82. Antioxidant activities of rosemary (Rosmarinus officinalis L.) extract, blackseed (Nigella sativa L.) essential oil, carnosic acid, rosmarinic acid and sesamol. Erkan N, Ayranci G, Ayranci E.

62 Food Chem. 2007;100(3):985–9. Antioxidant potentials and rosmarinic acid levels of the methanolic extracts of Salvia verticillata (L.) subsp. verticillata and S. verticillata (L.) subsp. amasiaca (Freyn & Bornm.) Bornm. Tepe B, Eminagaoglu O, Akpulat HA, Aydin E.

63 Food Chem. 2010;119(2):684–8. Antioxidant, antiinflammatory activities and HPLC analysis of South African Salvia species. Kamatou GPP, Viljoen AM, Steenkamp P.

64 J Lipid Mediat Cell Signal. 1997;17(3):207–20. Possible mechanisms for the differential effects of high linoleate safflower oil and high alpha-linolenate perilla oil diets on platelet-activating factor production by rat polymorphonuclear leukocytes. Oh-hashi K, Takahashi T, Watanabe S, Kobayashi T, Okuyama H.

65 Phytother Res. 2003;17(3):240–3. Anti-allergic effect of Perilla frutescens and its active constituents. Makino T, Furuta Y, Wakushima H, Fujii H, Saito K-I, Kano Y.